Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rylie M Hightower

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Muscle & Nerve|September 7, 2017
Genetic modifiers of Duchenne and facioscapulohumeral muscular dystrophiesRylie M Hightower, Matthew S Alexander
Muscle & Nerve|March 2, 2021
hnRNP L is essential for myogenic differentiation and modulates myotonic dystrophy pathologiesMatthew S Alexander, Rylie M Hightower, Andrea L Reid, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 20, 2019
The SINE Compound KPT-350 Blocks Dystrophic Pathologies in DMD Zebrafish and MiceRylie M Hightower, Andrea L Reid, Devin E Gibbs, et al.
Human Molecular Genetics|August 9, 2020
DOCK3 is a dosage-sensitive regulator of skeletal muscle and Duchenne muscular dystrophy-associated pathologiesAndrea L Reid, Yimin Wang, Adrienne Samani, et al.
Human Molecular Genetics|July 4, 2019
Selective serotonin reuptake inhibitors ameliorate MEGF10 myopathyMadhurima Saha, Skylar A Rizzo, Manashwi Ramanathan, et al.
JCI Insight|September 21, 2018
A limb-girdle muscular dystrophy 2I model of muscular dystrophy identifies corrective drug compounds for dystroglycanopathiesPeter R Serafini, Michael J Feyder, Rylie M Hightower, et al.
Life Science Alliance|May 5, 2022
miR-486 is essential for muscle function and suppresses a dystrophic transcriptomeAdrienne Samani, Rylie M Hightower, Andrea L Reid, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Muscle & Nerve|September 7, 2017
Genetic modifiers of Duchenne and facioscapulohumeral muscular dystrophiesRylie M Hightower, Matthew S Alexander
Muscle & Nerve|March 2, 2021
hnRNP L is essential for myogenic differentiation and modulates myotonic dystrophy pathologiesMatthew S Alexander, Rylie M Hightower, Andrea L Reid, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 20, 2019
The SINE Compound KPT-350 Blocks Dystrophic Pathologies in DMD Zebrafish and MiceRylie M Hightower, Andrea L Reid, Devin E Gibbs, et al.
Human Molecular Genetics|August 9, 2020
DOCK3 is a dosage-sensitive regulator of skeletal muscle and Duchenne muscular dystrophy-associated pathologiesAndrea L Reid, Yimin Wang, Adrienne Samani, et al.
Human Molecular Genetics|July 4, 2019
Selective serotonin reuptake inhibitors ameliorate MEGF10 myopathyMadhurima Saha, Skylar A Rizzo, Manashwi Ramanathan, et al.
JCI Insight|September 21, 2018
A limb-girdle muscular dystrophy 2I model of muscular dystrophy identifies corrective drug compounds for dystroglycanopathiesPeter R Serafini, Michael J Feyder, Rylie M Hightower, et al.
Life Science Alliance|May 5, 2022
miR-486 is essential for muscle function and suppresses a dystrophic transcriptomeAdrienne Samani, Rylie M Hightower, Andrea L Reid, et al.
Pageof 1